2m 2m 2m 2m 2m 2m 2m
C4 THERAPEUTICS (CCCC)
NASDAQ
$3.42-$0.06 (-1.87%)
Price as of Aug 03, 2026 10:03 AM EDT- $384.8MMarket Cap
- 64.15%1-Year Change
- BiotechnologyIndustry
C4 THERAPEUTICS (CCCC)
$3.42-$0.06 (-1.87%)
CCCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.48 | ||
Change | -$0.18 (-4.92%) | ||
Open | $3.66 | ||
High | $3.66 | ||
Low | $3.45 | ||
Previous Close | $3.66 | ||
Volume | 1,949,817 | ||
30-Day Average Volume | 3,151,332 | ||
1-Week Change | 2.35% | ||
1-Month Change | -25.48% | ||
1-Year Change | 64.15% | ||
3-Year Change | -10.54% | ||
5-Year Change | -91.93% | ||
Fundamentals | |||
Shares Outstanding | 110.6M | ||
Total Assets | $328.9M | ||
Market Cap | $384.8M | ||
Enterprise Value | $323.5M | ||
Period: QTR TTM FY | |||
Revenue | $6.2M | ||
Net Income | -$25.1M | ||
Free Cash Flow | -$30.0M | ||
EBIT | -$25.1M | ||
EBITDA | -$24.7M | ||
Net Working Capital | $218.1M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | 1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue